Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Expert Review of Anticancer Therapy
|
March 1, 2006
Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions
Chau T Dang
JAMA
|
October 9, 2013
Sentinel node biopsy after neoadjuvant chemotherapy: a new standard for patients with axillary metastases?
Monica Morrow, Chau T Dang
Breast Disease
|
February 3, 2005
Adjuvant therapy for breast cancer: practical lessons from the early breast cancer trialists' collaborative group
Clifford A Hudis, Chau T Dang
Oncology (Williston Park, N.Y.)
|
April 5, 2011
Anthracyclines are a critical component of adjuvant chemotherapy regimens for high-risk early breast cancer
Patrick G Morris, Clifford A Hudis, Chau T Dang
Oncology (Williston Park, N.Y.)
|
July 10, 2002
Potential role of selective COX-2 inhibitors in cancer management
Chau T Dang, Charles L Shapiro, Clifford A Hudis
Oncology (Williston Park, N.Y.)
|
December 20, 2003
Risk models for neutropenia in patients with breast cancer
Chau T Dang, Monica N Fornier, Clifford A Hudis
JACC. Cardiooncology
|
August 16, 2021
Trastuzumab Cures Cancer and Disrupts the Practice of Cardiology
Richard M Steingart, Anthony F Yu, Chau T Dang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2018
Risk-Imaging Mismatch: Why Is There a Disconnect?
Chau T Dang, Anthony F Yu, Jennifer Liu, et al.
Cancer
|
August 12, 2004
The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma
Rose Lai, Chau T Dang, Mark G Malkin, et al.
Breast Cancer Research and Treatment
|
July 12, 2012
Risk of rash with the anti-HER2 dimerization antibody pertuzumab: a meta-analysis
Aaron M Drucker, Shenhong Wu, Chau T Dang, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Expert Review of Anticancer Therapy
|
March 1, 2006
Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions
Chau T Dang
JAMA
|
October 9, 2013
Sentinel node biopsy after neoadjuvant chemotherapy: a new standard for patients with axillary metastases?
Monica Morrow, Chau T Dang
Breast Disease
|
February 3, 2005
Adjuvant therapy for breast cancer: practical lessons from the early breast cancer trialists' collaborative group
Clifford A Hudis, Chau T Dang
Oncology (Williston Park, N.Y.)
|
April 5, 2011
Anthracyclines are a critical component of adjuvant chemotherapy regimens for high-risk early breast cancer
Patrick G Morris, Clifford A Hudis, Chau T Dang
Oncology (Williston Park, N.Y.)
|
July 10, 2002
Potential role of selective COX-2 inhibitors in cancer management
Chau T Dang, Charles L Shapiro, Clifford A Hudis
Oncology (Williston Park, N.Y.)
|
December 20, 2003
Risk models for neutropenia in patients with breast cancer
Chau T Dang, Monica N Fornier, Clifford A Hudis
JACC. Cardiooncology
|
August 16, 2021
Trastuzumab Cures Cancer and Disrupts the Practice of Cardiology
Richard M Steingart, Anthony F Yu, Chau T Dang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2018
Risk-Imaging Mismatch: Why Is There a Disconnect?
Chau T Dang, Anthony F Yu, Jennifer Liu, et al.
Cancer
|
August 12, 2004
The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma
Rose Lai, Chau T Dang, Mark G Malkin, et al.
Breast Cancer Research and Treatment
|
July 12, 2012
Risk of rash with the anti-HER2 dimerization antibody pertuzumab: a meta-analysis
Aaron M Drucker, Shenhong Wu, Chau T Dang, et al.
Page
of 8